-
Live-Dead Cell Staining Kit I in Bone Research
2026-09-14
Use dual Calcein AM/PI fluorescence to separate viable mammalian cells from membrane-compromised cells in biomaterial, osteoporotic bone, and cytotoxicity studies. This workflow adds spatial, cell-level evidence to hydrogel compatibility testing while clarifying what a live/dead endpoint can—and cannot—prove.
-
Recombinant Human FGF-19: Assay Workflows
2026-09-14
Build reproducible FGFR4 binding, proliferation, and metabolic-signaling assays with a tag-free, validated FGF-19 format. This workflow also shows how to connect FGF-19 experiments with WIP1–p38 MAPK pyroptosis research while keeping evidence and hypothesis clearly separated.
-
Protease Inhibitor Cocktail for Causal Signaling Studies
2026-09-13
Learn how a Protease Inhibitor Cocktail can preserve protein abundance, complexes, and phosphorylation-sensitive readouts during extraction. This article connects EDTA-free inhibitor selection with mechanistic interpretation of the MLF2–p53–USP7 colorectal cancer pathway.
-
TRPM3 Regulation by Neurosteroids and Primidone
2026-09-12
Yin et al. combine cryo-EM, electrophysiology, molecular dynamics, and mass spectrometry to define how pregnenolone sulfate, CIM 0216, and primidone regulate TRPM3. The study links ligand-binding sites to channel gating and disease-associated gain-of-function mechanisms, providing a structural framework for TRPM3-directed pain and neurodevelopmental disorder research.
-
Cy5-UTP for RNA Probe Synthesis and QC
2026-09-11
Cy5-UTP enables direct, red-channel visualization of T7-transcribed RNA, making it useful for RNA probe synthesis, FISH, and process monitoring. Its strongest applied value is analytical: researchers can track RNA recovery and localization while preserving an unlabeled parallel batch for functional circRNA or vaccine studies.
-
Wnt-C59 as a Secretion-Gate Probe for Wnt Biology
2026-09-11
Wnt-C59 is a potent PORCN inhibitor for separating Wnt secretion from downstream pathway activity. This article develops a cross-domain assay framework linking cancer biology evidence with the lithium-engineered exosomal Wnt10a mechanism reported in osteogenesis research.
-
Sulfo-Cy3 azide for Aqueous Neuroimaging
2026-09-10
Sulfo-Cy3 azide combines an aqueous-compatible click handle with bright Cy3-range fluorescence for labeling alkyne-bearing oligonucleotides, proteins, and biological samples. This guide translates developmental claustrum mapping into a practical workflow, with controls and troubleshooting for cleaner fluorescent microscopy staining.
-
LuQi Formula, SPTLC2, and Post-MI Remodeling
2026-09-10
The reference study identifies SPTLC2-regulated de novo ceramide synthesis as a mechanistic contributor to post-myocardial infarction ventricular remodeling. Using rat and cardiomyocyte models, it shows that LuQi Formula reduces ceramide accumulation and apoptosis, providing a framework for studying sphingolipid metabolism in cardiac injury.
-
TCAIM–OGDH Control of Mitochondrial Metabolism
2026-09-09
Wang et al. identify TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. The study establishes mitochondrial proteostasis as a post-translational mechanism for limiting OGDH complex activity and reshaping carbohydrate catabolism in cells and mice.
-
JC-1 as a Pharmacodynamic Readout for Cancer Nanogels
2026-09-09
JC-1 transforms mitochondrial membrane potential into a ratiometric fluorescence signal that can clarify how localized cancer nanogels affect cell fate. This article connects JC-1 assay design with the formulation, uptake, ROS, and apoptosis findings reported for a palbociclib thermogel platform.
-
Astrocytic GAT-3 Shapes Dentate Gyrus Memory
2026-09-08
The reference study identifies astrocytic GAT-3 as an active signaling pathway rather than only a GABA-clearance mechanism in the dentate gyrus. By linking GABA uptake to astrocytic Ca2+, presynaptic GluN2B-containing NMDA receptors, excitatory transmission, and contextual fear memory, it provides a mechanistic framework for synaptic transmission research.
-
Toremifene vs Tamoxifen in Advanced Breast Cancer
2026-09-08
This Cochrane review synthesized randomized evidence comparing the selective estrogen receptor modulator toremifene with tamoxifen in advanced breast cancer. Across efficacy and safety outcomes, it found no convincing clinically important difference, supporting toremifene as an alternative while highlighting the limits of older endocrine-therapy trials.
-
ICAA Targets RIP3 in Ang II Cardiac Hypertrophy
2026-09-07
The 2026 reference study identifies isochlorogenic acid A as a direct regulator of RIP3 phosphorylation and connects this target to CaMKII-dependent cardiac hypertrophy. Using Ang II stimulation, transverse aortic constriction, RIP3 overexpression, and MLKL analysis, the authors define a RIP3/CaMKII mechanism that is distinct from canonical RIP3/MLKL necroptosis.
-
Streptavidin-Cy3 for Biohybrid Microrobot Imaging
2026-09-07
Learn how Streptavidin-Cy3 converts biotin-tagged probes into a practical fluorescence readout for barrier penetration, tumor-spheroid localization, IHC, IF, ISH, and flow cytometry. This workflow-focused guide connects a bright Cy3 signal with the deformable, magnetically guided Euglena gracilis platform while clearly separating validated reagent specifications from assay-development recommendations.
-
EGCG-Releasing 3D-Printed Bone Scaffolds
2026-09-05
This study evaluates a three-dimensional printed tricalcium phosphate scaffold designed to release (-)-Epigallocatechin gallate (EGCG) locally while supporting bone formation, vascularization, and suppression of osteoclast and osteosarcoma-related activity. Its main contribution is the integration of sustained EGCG delivery with a patient-specific calcium phosphate platform for low-load-bearing craniofacial defects.